Sign In
News Digest /
StockInvest.us
Author: StockInvest.us
09:07am, Monday, May 12, 2025
Southwest Gas Holdings, Inc. (NYSE: SWX) has released its quarterly financial results for Q1 2025, showing notable shifts in operations. The combined report covers both Southwest Gas Holdings and its main subsidiary, Southwest Gas Corporation dedicated to natural gas utility services.
Key Highlig...
09:06am, Monday, May 12, 2025
Company Overview
Imunon, Inc. (NASDAQ: IMNN) is a clinical-stage biotechnology company focused on developing innovative treatments through non-viral DNA technologies aimed at addressing various human diseases, including advanced ovarian cancer and infectious diseases.
Recent Developments
Lead cl...
09:05am, Monday, May 12, 2025
Company OverviewSolo Brands, Inc. (NYSE: DTC) reported its quarterly results for the three months ending March 31, 2025. The company has faced significant challenges, resulting in a net loss and operational setbacks, amidst discussions for potential debt restructuring.
Income Statement Highlights...
09:04am, Monday, May 12, 2025
Company Overview
MBX Biosciences, Inc. (NASDAQ: MBX) is a clinical-stage biopharmaceutical company focused on the development of precision peptide therapies for treating endocrine and metabolic disorders. The firm is advancing several candidates, including its lead product, canvuparatide (MBX 210...
09:04am, Monday, May 12, 2025
Lixte Biotechnology Holdings, Inc. (OTCBB: LIXT) focuses on developing cancer therapies, particularly through its lead compound, LB-100, which inhibits Protein Phosphatase 2A to enhance the efficacy of existing treatments.
Recent Financial Highlights (Q1 2025):
Revenues: $0 - No revenue generate...
09:03am, Monday, May 12, 2025
UFP Technologies, Inc. (NASDAQ: UFPT) Overview
UFP Technologies has reported its financial results for the first quarter of 2025, showing significant growth amid ongoing strategic acquisitions. However, there are both positive and negative aspects to highlight based on the income statement.
Key F...
09:02am, Monday, May 12, 2025
1stdibs.com, Inc. (NASDAQ: DIBS) has reported its financial results for the first quarter ending March 31, 2025. The company is a leading online marketplace for luxury design items, connecting sellers and buyers in vintage and contemporary furniture, décor, and fashion.
Key Financial Highlights:
...
09:02am, Monday, May 12, 2025
Centuri Holdings, Inc. (NYSE: CTRI) - Q1 2025 Earnings Overview
Centuri Holdings, Inc., a utility infrastructure services provider, reported its quarterly results for the period ending March 30, 2025. The company’s financials reflect both resilience in revenue growth and ongoing challenges in ope...
09:01am, Monday, May 12, 2025
Company Overview:Sonida Senior Living, Inc. (NYSE: CSU) is a prominent figure in the senior living sector, focused on independent, assisted living, and memory care services. The company operates in 94 senior housing communities across 20 states, serving around 10,000 residents as of March 31, 202...
09:00am, Monday, May 12, 2025
Forrester Research, Inc. (NASDAQ: FORR) has reported its quarterly earnings for the period ending March 31, 2025. The company has faced significant challenges this quarter, particularly regarding revenue performance and a major goodwill impairment.
Key Financial Highlights:
Total Revenues: $89.9...
08:05am, Monday, May 12, 2025
Rockwell Medical, Inc. (NASDAQ: RMTI) has reported its financial results for the first quarter of 2025, revealing both challenges and areas for potential improvement as it continues its focus on the hemodialysis market.
Key Financial Highlights:
Net Sales: $18.9 million for Q1 2025, down 17% fro...
08:05am, Monday, May 12, 2025
Avalo Therapeutics, Inc. (NASDAQ: AVTX) has recently released its quarterly financial results for the period ending March 31, 2025. Below is a summary of the company's current financial condition, emphasizing key aspects of its income statement.
Positive Aspects:
Reduced Net Loss: Net loss narro...
08:04am, Monday, May 12, 2025
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) is a clinical-stage genetic medicine company focused on hereditary and acquired diseases. The company aims to develop gene therapy-based treatments using adeno-associated viruses (AAVs).
As of March 31, 2025, Lexeo reported substantial financial metrics tha...
08:03am, Monday, May 12, 2025
Tango Therapeutics, Inc. (NASDAQ: TNGX) has released its financial results for the first quarter of 2025, demonstrating a complex scenario characterized by both promising developments and ongoing challenges.
Key Points and Statistics:
Collaboration Revenue: $5.4 million for Q1 2025, down from $6...
08:02am, Monday, May 12, 2025
**Company Overview:**
Akero Therapeutics, Inc. (NASDAQ: AKRO) is a clinical-stage biotechnology company engaged in developing innovative treatments for serious metabolic diseases, particularly metabolic dysfunction-associated steatohepatitis (MASH). The company’s lead product candidate, Efruxif...